← Back to all trials
Not Yet Recruiting
NCT07664787
Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study
Conditions: Hypertension, Grade 1
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 20
Sponsor: Ruijin Hospital
Summary
Prospective, Multi-Center, Randomized, shame-Controlled, Uptake clinical trial to evaluate the efficacy and safety of the six-channel radio-frequency（RF) renal denervation system-comprising the six-channel RF generator (specification model: 25D1G, software release version: SRG-V1) and the disposable ultra-guiding RF denervation catheter (specification model: 25C6W127F115T)-for renal denervation in patients with grade I hypertension and without taking antihypertensive medicines.
Eligibility Criteria
Inclusion Criteria:
1. Male or female, aged 18 to 65 years inclusive
2. Hypertension duration longer than 3 months
3. Hypertensive subjects who have been stopped taking antihypertensive drugs continuously and stably for at least 4 weeks or who do not take antihypertensive drugs , with office systolic/diastolic blood pressure still ≥140/90 mmHg and \
Source: ClinicalTrials.gov (NCT07664787). StuddyBuddy aggregates publicly available trial information.
